InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by SOLAND DANIEL B, Chief Operating Officer. Director active across 1 companies, notably Idera Pharmaceuticals, INC.. In total, 2 reports have been logged. Total volume traded: €100k. The latest transaction was disclosed on 18 June 2021 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
€49,94450,000 shares@ €0.9989100.0% of flow
Common Stock
SEC:0001415889-21-003112·
Ideal exit: 15 Mar 2022 (T+270)
€49,94450,000 shares@ €0.998950.0% of flow
Common Stock
SEC:0001415889-21-003112:0·
Ideal exit: 15 Mar 2022 (T+270)
2 of 2 declarations
About SOLAND DANIEL B
Daniel B. Soland is the Chief Operating Officer of IDERA PHARMACEUTICALS, INC. In this role, he is responsible for managing the daily operations of the company. His expertise in the pharmaceutical sector and ability to lead teams enable him to optimize operational processes and improve efficiency.
